FGHQF (Frontage Holdings) EBIT: $19.1 Mil (TTM As of Dec. 2025)


FGHQF Frontage Holdings Corp FGHQF
58 GF Score
Price $0.14
GF Value $0.21
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Frontage Holdings EBIT?

Frontage Holdings FGHQF -3.57% 58 EBIT is $19.1 Mil as of Dec. 2025. GuruFocus rates FGHQF with a GF Score™ of 58/100 and a GF Value™ of $0.21 (Possible Value Trap). The stock has 8 warning signs investors should review.

Frontage Holdings's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was $9.8 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was $19.1 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Frontage Holdings's annualized ROC % for the quarter that ended in Dec. 2025 was 2.61%. Frontage Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 9.89%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Frontage Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 5.66%.


Frontage Holdings  (OTCPK:FGHQF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Frontage Holdings's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=21.654 * ( 1 - 40.76% )/( (494.967 + 486.661)/ 2 )
=12.8278296/490.814
=2.61 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=544.268 - 23.388 - ( 33.662 - max(0, 106.343 - 132.256+33.662))
=494.967

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=541.024 - 19.693 - ( 39.144 - max(0, 103.496 - 138.166+39.144))
=486.661

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Frontage Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=19.636/( ( (175.67 + max(23.566, 0)) + (168.584 + max(29.348, 0)) )/ 2 )
=19.636/( ( 199.236 + 197.932 )/ 2 )
=19.636/198.584
=9.89 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(63.379 + 2.967 + 8.977) - (23.388 + 0 + 28.369)
=23.566

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(62.533 + 2.979 + 11.324) - (19.693 + 0 + 27.795)
=29.348

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Frontage Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=19.14/337.973
=5.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Frontage Holdings EBIT Related Terms


Frontage Holdings EBIT Historical Data

* Premium members only.

The historical data trend for Frontage Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frontage Holdings EBIT Chart

Frontage Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.65 40.04 21.65 12.31 19.14

Frontage Holdings Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.13 4.69 7.62 9.32 9.82

FGHQF vs VRTX, REGN, ALNY: EBIT Comparison

For the Biotechnology subindustry, Frontage Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Frontage Holdings EV-to-EBIT vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Frontage Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Frontage Holdings's EV-to-EBIT falls into.


FGHQF
58GF Score
Frontage Holdings Corp FGHQF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Frontage Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $19.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $19.1 Mil mean?
Frontage Holdings (FGHQF) has a EBIT of $19.1 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Frontage Holdings.
Is Frontage Holdings' EBIT too high?
Frontage Holdings' current EBIT is $19.1 Mil. Overall, Frontage Holdings has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Frontage Holdings' EBIT compare to VRTX and REGN?
Frontage Holdings' EBIT of $19.1 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Biotechnology company?
A good EBIT depends on the Biotechnology industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Frontage Holdings. Frontage Holdings's current EBIT is $19.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Frontage Holdings stock overvalued right now?
Based on GuruFocus' analysis, Frontage Holdings (FGHQF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.21, compared to a current price of $0.14 — trading 35.7% below its estimated fair value. The current EBIT is $19.1 Mil. Frontage Holdings' overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Frontage Holdings (FGHQF), the current EBIT is $19.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Frontage Holdings (FGHQF) Overvalued in 2026?

Based on GuruFocus' analysis, Frontage Holdings stock appears to be undervalued. The current stock price of $0.14 is trading 35.7% below its estimated GF Value™ of $0.21. GuruFocus considers Frontage Holdings to be Possible Value Trap.

Key valuation signals for FGHQF:

  • EBIT: $19.1 Mil
  • GF Value™: $0.21 vs. price of $0.14 (35.7% below fair value)
  • GF Score™: 58/100 with 8 warning signs

No single metric tells the full story. See the FGHQF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Frontage Holdings Business Description

Other Exchanges 01521:Hong Kong
Address 700 Pennsylvania Drive, Exton, PA, USA, 19341
Frontage Holdings Corp provides laboratory and related services to pharmaceutical and agrochemical companies. Its segments include North America and Europe segment, including drug discovery, drug development, pharmaceutical product development and laboratory testing in the USA, Canada and Europe; and PRC segment, including drug discovery, drug development, pharmaceutical product development and laboratory testing in the PRC. It derives majority of the revenue from North America and Europe segment. Geographically majority of the revenue is derived from USA and Canada.
58GF Score

Get the complete analysis for FGHQF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.14
Price
$0.21
GF Value